House and Senate Appropriators Pledge to Increase Biomedical Research Funding.
Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center
Clinical Trials: NIH Health Plans Association, Agree In Principle to Raise Clinical Trial Enrollment
Cancer Screenings: American Over 50 Urged to Get Colon Caner Tests
Cancer Prevention: HHS Calls for Warning Labels on Cigars, Says Teen Use High
Funding Opportunities: NCI Offers Grant Supplements
Foon To Direct Barrett Center; Hundahl Leads Commission
National Comprehensive Center Network, Quintiles Oncology, To Collaborate On Trials
Oncology ManagementL Tax-Exempt Bonds Issued To Expand UPCI; Sentillion, Dua Partner on Info System
Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says
Approvals and Applications: European Committee Signs Off On Paxene for KS reatment
Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms
Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol
Oncology ManagementL AOR earns $30 Million, PRN Earns $29.8 Million
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial
